MoneyWorks4Me

A minor change in the total revenue was seen in the March 2022 quarter. The total revenue for the quarter stood at Rs. 707.48 millions against Rs. 706.08 millions during year ago period.Net profit declined -5.83% to Rs. 143.52 millions from Rs. 152.40 millions.A decline of 205.52 millions was observed in the OP in the quarter ended March 2022 from 245.12 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 707.48 706.08 0.20 2727.98 2834.73 -3.77 2727.98 2834.73 -3.77
Other Income 51.69 25.84 100.04 90.80 68.23 33.08 90.80 68.23 33.08
PBIDT 205.52 245.12 -16.16 817.28 1075.34 -24.00 817.28 1075.34 -24.00
Interest 0.52 0.09 477.78 0.95 1.00 -5.00 0.95 1.00 -5.00
PBDT 205.00 245.03 -16.34 816.33 1074.34 -24.02 816.33 1074.34 -24.02
Depreciation 25.34 24.35 4.07 95.61 90.06 6.16 95.61 90.06 6.16
PBT 179.66 220.68 -18.59 720.72 984.28 -26.78 720.72 984.28 -26.78
TAX 36.14 68.28 -47.07 175.61 274.16 -35.95 175.61 274.16 -35.95
Deferred Tax -3.52 13.46 -126.15 -4.56 25.72 -117.73 -4.56 25.72 -117.73
PAT 143.52 152.40 -5.83 545.11 710.12 -23.24 545.11 710.12 -23.24
Equity 223.60 223.46 0.06 223.60 223.46 0.06 223.60 223.46 0.06
PBIDTM(%) 29.05 34.72 -16.32 29.96 37.93 -21.02 29.96 37.93 -21.02
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..